Biomarker, Innovation, Research
November 3, 2022
Via: Medical Device NetworkDutch company Enzyre has raised $11.85m (€12m) in a Series A financing round to accelerate the development of its ambulant diagnostic technology platform for haemophilia patients. Led by new investor Oost NL, the financing round also saw participation from Demcon […]
March 28, 2024
April 19, 2024